0.00Open0.00Pre Close0 Volume0 Open Interest195.00Strike Price0.00Turnover346.06%IV-155.20%PremiumDec 20, 2024Expiry Date118.59Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9962Delta0.0008Gamma0.64Leverage Ratio-0.0100Theta-0.0047Rho-0.64Eff Leverage0.0008Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet